BEIJING, Sept. 28, 2026 (GLOBE NEWSWIRE) — Julong Holding Limited (“Julong” or the “Company”) (Nasdaq: JLHL), a growth-oriented provider of intelligent integrated solutions, today announced that, on September 28, 2026, it entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors for a private placement (the “Private Placement”) of the Company’s securities. Under the terms of the Securities Purchase Agreement, the Company agreed to issue and sell (i) 750,000 Class A ordinary shares (the “Class A Ordinary Shares”), par value US$0.0001 per share, of the Company (the “Initial Shares”), at a purchase price of US$0.300 per share, and (ii) 2,250,000 pre-funded warrants to purchase up to an aggregate of 2,250,000 Class A Ordinary Shares (the “Pre-Funded Warrants,” together with the Initial...

All measurable sequencing metrics show profound improvement over Platinum Pro BRANFORD, Conn., Sept. 28, 2026 (GLOBE NEWSWIRE) — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced interim development results comparing its next-generation Proteus™ platform with its commercially available Platinum® Pro instrument. Using a developmental sequencing kit that detects 18 amino acids, Proteus significantly outperformed Platinum Pro across every key measure, from sequencing scale and accuracy to peptide identification and protein sequence coverage, even though the Proteus instrument, consumable, loading protocol and analysis software are still in development and not yet fully optimized. The data will...

SAN DIEGO, Sept. 28, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that its data will be presented at the Euretina Innovation Spotlight (EIS) being held on September 30, 2026, and Euretina being held on October 1-4, 2026, in Vienna, Austria. EIS Presentation DetailsSession: EURETINA Innovation Spotlight – Inherited and Rare Retinal DiseasesTitle: Belite Bio Company OverviewPresenter: Hendrik Scholl, M.D., Chief Medical Officer, Belite BioDate and Time: September 30, 2026, 2:28 – 3:06 p.m. CESTLocation: Vienna Congress & Convention Center, Room 1/Hall A Euretina Presentation DetailsSession: EURETINA Free...

— Filing seeks approval for a biomarker-directed, all-oral treatment option for patients whose tumors have MET overexpression or amplification, after progression on an EGFR-TKI therapy — — Application supported by SAFFRON, the first global Phase III trial to demonstrate statistically significant and clinically meaningful improvements in progression-free and overall survival in this setting — — SAFFRON builds on evidence from the SACHI Phase III and SAVANNAH Phase II trials — HONG KONG, SHANGHAI and FLORHAM PARK, N.J., Sept. 28, 2026 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that AstraZeneca has submitted a New Drug Application (“NDA”) to the US Food and Drug Administration (“FDA”) for ORPATHYS® (savolitinib) plus TAGRISSO® (osimertinib) for the treatment of patients with locally...

TORONTO, Sept. 28, 2026 (GLOBE NEWSWIRE) — Energy Income Fund (TSX – ENI.UN) (the “Fund”) is pleased to announce that unitholders will have the opportunity to redeem up to 253,384 units (the “Units”) of the Fund. The annual redemption date has been set for November 27, 2026. Units will be redeemed for an amount per Unit equal to net asset value less redemption costs equal to 5% of net asset value per Unit plus applicable taxes (as contemplated in the Fund’s declaration of trust which is available on the Fund’s SEDAR+ profile at www.sedarplus.ca). If requests for redemptions exceed 253,384 Units, Units will be redeemed on a pro rata basis. In order to redeem their Units, holders must deliver a redemption notice to their broker sufficiently in advance to ensure that such notice is then delivered to the Fund’s transfer agent by no...

VANCOUVER, British Columbia, Sept. 28, 2026 (GLOBE NEWSWIRE) — Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) today issued the following letter to shareholders from Chris Adams, President and CEO.Dear Fellow Shareholders, Autumn is off to a very busy start at Entrée. Since my appointment as President and CEO in July, I have been focused on building personal relationships with many of our larger shareholders, our Joint Venture partner, and other key stakeholders. Most importantly, I traveled to Mongolia at the start of September to personally see our interest in the Oyu Tolgoi copper-gold project and to meet Entrée’s Mongolian employees as well as in-country representatives of Rio Tinto and Oyu Tolgoi LLC, the Minister of Industry and Mineral Resources, and certain leaders in the business community. We...

LAS VEGAS, Sept. 28, 2026 (GLOBE NEWSWIRE) — Galaxy Gaming, Inc.® (OTC: GLXZ), the world’s leading independent developer and distributor of casino table games and technology, today announced that MONOPOLY® Table Games Progressive has been named Product Innovation of the Year at the Global Gaming Awards Americas 2026, held in Las Vegas. MONOPOLY Table Games Progressive, developed through Galaxy Gaming’s exclusive licensing agreement with Hasbro®, transforms one of the world’s most recognizable brands into a linked progressive table game experience. Since launch, the game has quickly become one of the industry’s most talked-about new products, with installations now spanning North America and EMEA. “This recognition means a great deal to our entire team,” said Matt Reback, President and CEO of Galaxy Gaming....